1 Feigin A, Vos T, Nicholas E, et al. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020;19:255–65.
2 Gustavsson A, Svensson M, Jakobi F, et al. Cost of Disorders of the Brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718–79.
3 Maercker A, Perkonigg A, Preisig M, et al. The costs of disorders of the brain in Switzerland: An update from the European Brain Councl study for 2010. Swiss Med Wkly. 2013;143.
4 Bassetti CL, Hess CW, Steck A, Ludin HP. A 110-year history of the Swiss Neurological Society (SNG) through the biosketches of its first 42 presidents. Clinical and Translational Neurosci. 2018;2:DOI: 10.1177/2514183X18788797.
5 Bassetti CL, Galimanis A, Du Pasquier R. The new Swiss postgraduate training (residency program) in neurology: Making Swiss neurologists more competitive. Clinical and Translational Neurosci. 2018;2:DOI: 10.1177/2514183X18792760.
6 Ropper AH. Two Centuries of Neurology and Psychiatry in the Journal. New Engl J Med. 2012;367:58–65.
7 Jung HH, Arnold M, Du Pasquier R, et al. Progrès fulgurants en neurologie (1re partie). Bull Med Suisses. 2017;98:1394–5.
8 Jung HH, Baumann CL, Kälin A, et al. Progrès fulgurants en neurologie (2e partie). Bull Med Suisses. 2017;98:1440–1.
9 Finkel RS, Mercuri E, Darras BT, et al. Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. N Engl J Med. 2017;377:1723–32.
10 Tabrizi SJ, Leavitt BR, Landwehrmeyer GB, et al. Targeting Huntingtin Expression in Patients with Huntington’s Disease. N Engl J Med. 2019;380:2307–16.
11 Miller TD, Cudkowicz PJ, Shaw PM, et al. Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N Engl J Med. 2020;383:109–19.
12 Bassetti C, Merlo A, Steinlin M, Valavanis A, Weder B. SFCNS: Eine starke Allianz der klinischen Neurodisiplinen. Bull Med Suisses. 2013;94:870–2.
13 Deuschl G. The future of neurology in Europe. Clinical and Translational Neuroscience. 2017;1:1–4.
14 Sacco RL. Neurology. Challenges, opportunities, and the way forward. Neurology 2019.
15 Bassetti CLA, Fazekas F. The European Academy of Neurology is 6 years old: challenges, opportunities and strategic priorities for the future. Eur J Neurol. 2020;27:1351–3.